Tab Febuxtat dose
Febuxostat (Uloric) is a xanthine oxidase inhibitor used for chronic gout. Standard dosing: 40 mg once daily, may increase to 80 mg once daily if uric acid remains above target.
Searching sources...
Reading File
Searching the Web
Febuxostat dose gout 2024 guidelines
Finding Sources
Reading File
Reading File
Febuxostat (Tab Febuxostat) - Complete Dosing Guide
Drug class: Non-purine selective xanthine oxidase (XO) inhibitor
Indication: Chronic hyperuricemia in gout (NOT for asymptomatic hyperuricemia)
Dosing
| Step | Dose | Timing |
|---|---|---|
| Initial | 40 mg once daily | With or without food |
| Uptitration | 80 mg once daily | If serum uric acid (sUA) remains >6 mg/dL after 2 weeks |
- FDA-approved doses: 40 mg and 80 mg only (120 mg used in some trials but not FDA-approved due to CV concerns)
- Target sUA: <6.0 mg/dL (360 µmol/L); for tophaceous gout, aim <5 mg/dL
Renal / Hepatic Impairment
- No dose adjustment needed for mild-to-moderate renal or hepatic impairment - febuxostat is primarily liver-metabolized
- Use with caution if eGFR <30 mL/min (limited data for severe renal impairment)
Pharmacokinetics
| Parameter | Value |
|---|---|
| Absorption | >80% oral bioavailability; Tmax ~1-1.5 h |
| Half-life | 4-8 hours (once-daily dosing effective) |
| Metabolism | Hepatic (UGT1A1, 1A3, 1A9, 2B7; CYP1A2, 2C8, 2C9) |
| Excretion | Hepatic + renal; <5% unchanged in urine |
Note: Antacids (Mg(OH)2, Al(OH)3) delay absorption ~1 h. Food slightly reduces absorption but is clinically insignificant.
Key Precautions
- Boxed Warning: Possible increased risk of cardiovascular death vs. allopurinol (though subsequent data have not confirmed this - CARES trial signal not replicated)
- Gout flares on initiation are common - co-prescribe colchicine or an NSAID prophylactically at the start of therapy
- Contraindicated with azathioprine or mercaptopurine (XO inhibition raises their toxic metabolite levels - risk of life-threatening bone marrow suppression)
- Monitor liver function tests periodically
Place in Therapy
- Second-line after allopurinol (allopurinol is preferred as first-line)
- Good choice when: allopurinol is not tolerated / prior hypersensitivity / insufficient dose escalation due to renal impairment
- 40 mg febuxostat ~ 300 mg allopurinol in urate lowering; 80 mg febuxostat > 300 mg allopurinol
Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics; Katzung's Basic and Clinical Pharmacology 16th Ed; Comprehensive Clinical Nephrology 7th Ed
This is a shared conversation. Sign in to Orris to start your own chat.